Medicines
Shortlist up to four to read them side by side.
704 medicine recalls FDA’s Enforcement Report published in 2026, the newest year, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
704of 704 medicine recallsshown with your filters
The list
- Medicine recall Fluocinonide, USP, 0.05% Cream, 60g tube Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL Labelling: Illegible label Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Remedy Gel, hydrocortisone 1%, 30 mL/ 1 fl oz per bottle Subpotent Drug Class IIIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Skin Rehab, Calming Skin Gel, Hydrocortisone Balm, hydrocortisone 1%, .53oz Subpotent Drug Class IIIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Essential Calming Skin Gel, hydrocortisone 1%, 120mL/4oz Subpotent Drug Class IIIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall EPINEPHRINE Injection, USP, 1 mg/10mL Lack of Assurance of Sterility Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules Failed Dissolution Specifications Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz Failed Stability Specifications Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), Avantor… Subpotent drug Class IIIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Lidocaine HCl injection, USP, 1% 50mg/5mL Lack of Assurance of Sterility Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Bupivacaine Hydrochloride 0.75% Lack of Assurance of Sterility Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall 0.9% Sodium Chloride Injection, USP, 10 mL Ampules Lack of Assurance of Sterility Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Lidocaine HCl Injection, USP, 2%, 100 mg/5mL Lack of Assurance of Sterility Class IIFDA’s classApr 22, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 22, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall 0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP 0.9% Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, 0.9% Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes,… Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 5% Dextrose Injection, USP 2.5 g per 50 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 5% Dextrose Injection, USP 5 g per 100 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall 5% Dextrose Injection, USP 12.5 g per 250 mL Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide, and Alaska and Puerto Rico named
- Medicine recall norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710… Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710… Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710… Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710… Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710… Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz… Lack of Assurance of Sterility Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles Failed Dissolution Specifications Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Isotretinoin Capsules, USP, 30 mg Superpotent and Subpotent Class IIFDA’s classApr 15, 2026in FDA’s Enforcement Report4 statesnamed in where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereFlorida, Mississippi, Ohio and Puerto Rico
- Medicine recall Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs Superpotent and Subpotent Class IIFDA’s classApr 15, 2026in FDA’s Enforcement Report4 statesnamed in where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereFlorida, Mississippi, Ohio and Puerto Rico
- Medicine recall GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL Presence of particulate matter Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL Presence of particulate matter Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers CGMP Deviations: use of an unapproved raw material Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNot namedno state, in where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNo state named
- Medicine recall Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers CGMP Deviations: use of an unapproved raw material Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNot namedno state, in where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNo state named
- Medicine recall Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers CGMP Deviations: use of an unapproved raw material Class IIFDA’s classApr 15, 2026in FDA’s Enforcement ReportNot namedno state, in where it went PublishedApr 15, 2026ClassClass IIStatusOngoingWhereNo state named
- Medicine recall traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval… Class IIFDA’s classApr 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl Lack of Assurance of Sterility Class IIFDA’s classApr 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall EYE DROPS Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5… Lack of Assurance of Sterility Class IIFDA’s classApr 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 8, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL OZ Lack of Assurance of Sterility Class IIFDA’s classApr 8, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 8, 2026ClassClass IIStatusOngoingWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.